nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors
|
de Heuvel, Erik |
|
|
27 |
18 |
p. 3998-4012 |
artikel |
2 |
Alkynamide phthalazinones as a new class of TbrPDEB1 inhibitors (Part 2)
|
de Heuvel, Erik |
|
|
27 |
18 |
p. 4013-4029 |
artikel |
3 |
C-glyco“RGD” as αIIbβ3 and αvβ integrin ligands for imaging applications: Synthesis, in vitro evaluation and molecular modeling
|
Vucko, Timothé |
|
|
27 |
18 |
p. 4101-4109 |
artikel |
4 |
Design and synthesis of sulfonamidophenylethylamides as novel cardiac myosin activator
|
Manickam, Manoj |
|
|
27 |
18 |
p. 4110-4123 |
artikel |
5 |
Design of hybrid molecules as antimycobacterial compounds: Synthesis of isoniazid-naphthoquinone derivatives and their activity against susceptible and resistant strains of Mycobacterium tuberculosis
|
Reis, Wallace J. |
|
|
27 |
18 |
p. 4143-4150 |
artikel |
6 |
Design, synthesis and anti-inflammatory evaluation of novel pyrrolo[2,3-d]pyrimidin derivatives as potent JAK inhibitors
|
Jiang, Feng |
|
|
27 |
18 |
p. 4089-4100 |
artikel |
7 |
Design, synthesis and biological evaluation of novel dithiocarbamate-substituted diphenylaminopyrimidine derivatives as BTK inhibitors
|
Zhai, Zheng |
|
|
27 |
18 |
p. 4124-4142 |
artikel |
8 |
Development of 99mTc radiolabeled A85380 derivatives targeting cerebral nicotinic acetylcholine receptor: Novel radiopharmaceutical ligand 99mTc-A-YN-IDA-C4
|
Mori, Daisuke |
|
|
27 |
18 |
p. 4200-4210 |
artikel |
9 |
Editorial Board
|
|
|
|
27 |
18 |
p. ii |
artikel |
10 |
Effect of Panax ginseng combined with Angelica sinensis on the dissolution of ginsenosides and in chemotherapy mice hematopoietic function
|
Zheng, Xiaoman |
|
|
27 |
18 |
p. 4211-4218 |
artikel |
11 |
Evaluation of α-hydroxycinnamic acids as pyruvate carboxylase inhibitors
|
Burkett, Daniel J. |
|
|
27 |
18 |
p. 4041-4047 |
artikel |
12 |
Graphical abstract TOC
|
|
|
|
27 |
18 |
p. OBC |
artikel |
13 |
Graphical abstract TOC
|
|
|
|
27 |
18 |
p. IBC |
artikel |
14 |
Graphical abstract TOC continued
|
|
|
|
27 |
18 |
p. I-VI |
artikel |
15 |
Microwave-Assisted Organic Synthesis, structure–activity relationship, kinetics and molecular docking studies of non-cytotoxic benzamide derivatives as selective butyrylcholinesterase inhibitors
|
Wajid, Sheeba |
|
|
27 |
18 |
p. 4030-4040 |
artikel |
16 |
Molecular modelling, synthesis, and biological evaluations of a 3,5-disubstituted isoxazole fatty acid analogue as a PPARα-selective agonist
|
Arnesen, Henriette |
|
|
27 |
18 |
p. 4059-4068 |
artikel |
17 |
Novel epidithiodiketopiperazines as anti-viral zinc ejectors of the Feline Immunodeficiency Virus (FIV) nucleocapsid protein as a model for HIV infection
|
Asquith, Christopher R.M. |
|
|
27 |
18 |
p. 4174-4184 |
artikel |
18 |
Novel multitarget 5-arylidenehydantoins with arylpiperazinealkyl fragment: Pharmacological evaluation and investigation of cytotoxicity and metabolic stability
|
Czopek, Anna |
|
|
27 |
18 |
p. 4163-4173 |
artikel |
19 |
Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses
|
da Silva-Júnior, Edeildo Ferreira |
|
|
27 |
18 |
p. 3963-3978 |
artikel |
20 |
Preparation and biological evaluation of soluble tetrapeptide epoxyketone proteasome inhibitors
|
Lei, Meng |
|
|
27 |
18 |
p. 4151-4162 |
artikel |
21 |
Structure-activity analysis of peptidic Chlamydia HtrA inhibitors
|
Agbowuro, Ayodeji A. |
|
|
27 |
18 |
p. 4185-4199 |
artikel |
22 |
Structure-aided optimization of 3-O-β-chacotriosyl ursolic acid as novel H5N1 entry inhibitors with high selective index
|
Liao, Yixian |
|
|
27 |
18 |
p. 4048-4058 |
artikel |
23 |
Synthesis and biological activity of structurally diverse phthalazine derivatives: A systematic review
|
Sangshetti, Jaiprakash |
|
|
27 |
18 |
p. 3979-3997 |
artikel |
24 |
Synthesis and evaluation of novel potent TSPO PET ligands with 2-phenylpyrazolo[1,5-a]pyrimidin-3-yl acetamide
|
Hieu Tran, Van |
|
|
27 |
18 |
p. 4069-4080 |
artikel |
25 |
Synthesis of quinoline derivatives as diabetic II inhibitors and molecular docking studies
|
Taha, Muhammad |
|
|
27 |
18 |
p. 4081-4088 |
artikel |